☆ 4.7 Article

Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis

BIOMEDICINES (2022)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Evidence of Oligoclonal Bands Does Not Exclude Non-Inflammatory Neurological Diseases

Katharina Pannewitz-Makaj et al.

Summary: Cerebrospinal fluid analysis is crucial for the diagnosis of neurological disorders, with evidence of immunoglobulin synthesis being more common in inflammatory diseases. However, this phenomenon can also be found at a low frequency in non-inflammatory diseases.

DIAGNOSTICS (2021)

Add to Collection

Article Cell Biology

Kappa Free Light Chains in the Context of Blood Contamination, and Other IgA- and IgM-Related Cerebrospinal Fluid Disease Pattern

Malte Johannes Hannich et al.

Summary: In this study, researchers investigated the synthesis of intrathecal FLC-k in cerebrospinal fluid samples from 296 patients. They found that FLC-k synthesis can occur independently of the antibody class produced, and can help distinguish between an inflammatory process and blood contamination. This suggests that additional determination of FLC-k in quotient diagrams may aid in clinical diagnostics.

CELLS (2021)

Add to Collection

Review Cell Biology

The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis

Franz Felix Konen et al.

Summary: Free light chains (FLC), particularly the kappa isoform (KFLC), show high diagnostic sensitivity and specificity in detecting intrathecal inflammation in central nervous system diseases. The measurement of KFLC is fully automated, stable against most influencing factors, and represents a promising diagnostic approach for neuroinflammatory diseases. Further multicenter studies are needed to establish the diagnostic sensitivity and specificity of KFLC, using standardized cut-off values and non-linear formulas.

CELLS (2021)

Add to Collection

Review Clinical Neurology

Deciphering Multiple Sclerosis Progression

Virginia Meca-Lallana et al.

Summary: Multiple sclerosis is an inflammatory and degenerative disease of the central nervous system triggered by unknown environmental factors in patients with genetic risk profiles. Prevention of neurological disability is essential, but mechanisms driving disease progression remain unknown. Lack of markers for early detection and varying definitions of disability progression complicate assessment in clinical practice.

FRONTIERS IN NEUROLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world investigation

Igal Rosenstein et al.

Summary: The Kappa free light chain (KFLC) index shows high sensitivity and specificity in the diagnosis of multiple sclerosis (MS), with similar accuracy to OCB and KFLCIF. Furthermore, the KFLC index is not influenced by disease-modifying therapy, demographic factors, or other inflammatory or degenerative processes in the cerebrospinal fluid.

JOURNAL OF NEUROCHEMISTRY (2021)

Add to Collection

Article Clinical Neurology

Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity

Klaus Berek et al.

Summary: The study demonstrates that high κ-FLC index is an independent predictor for disease activity in early multiple sclerosis. Among patients with early MS, high κ-FLC index is a significant risk factor for early second clinical attack.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)

Add to Collection

Review Clinical Neurology

The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid

Franz F. Konen et al.

Summary: The study found that decreased renal function leads to a decline in KFLC indices and KFLC IF values, affecting the interpretation of KFLC results in patients with neuroinflammatory diseases. In samples with inflammatory CSF profiles, false negative KFLC results may occur.

JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE (2021)

Add to Collection

Article Clinical Neurology

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study

C. E. Leurs et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Add to Collection

Article Immunology

Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders

P. Cavalla et al.

JOURNAL OF NEUROIMMUNOLOGY (2020)

Add to Collection

Article Medical Laboratory Technology

Clinical Use of κ Free Light Chains Index as a Screening Test for Multiple Sclerosis

Luisa Agnello et al.

LABORATORY MEDICINE (2020)

Add to Collection

Article Immunology

Free light chain kappa and the polyspecific immune response in MS and CIS - Application of the hyperbolic reference range for most reliable data interpretation

Marie Suesse et al.

JOURNAL OF NEUROIMMUNOLOGY (2020)

Add to Collection

Article Clinical Neurology

Free light chains kappa can differentiate between myelitis and noninflammatory myelopathy

Marie Suesse et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

Add to Collection

Article Multidisciplinary Sciences

Intrathecal kappa free light chains as markers for multiple sclerosis

D. Vecchio et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Review Clinical Neurology

Epidemiology and treatment of multiple sclerosis in elderly populations

Caila B. Vaughn et al.

NATURE REVIEWS NEUROLOGY (2019)

Add to Collection

Review Clinical Neurology

Age and the risks of high-efficacy disease modifying drugs in multiple sclerosis

Finja Schweitzer et al.

CURRENT OPINION IN NEUROLOGY (2019)

Add to Collection

Article Medical Laboratory Technology

Diagnostic relevance of free light chains in cerebrospinal fluid - The hyperbolic reference range for reliable data interpretation in quotient diagrams

Hansotto Reiber et al.

CLINICA CHIMICA ACTA (2019)

Add to Collection

Article Medicine, General & Internal

Reiber's Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis?

Philipp Schwenkenbecher et al.

DIAGNOSTICS (2019)

Add to Collection

Article Clinical Neurology

Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis

Emma Rathbone et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Add to Collection

Article Clinical Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson et al.

LANCET NEUROLOGY (2018)

Add to Collection

Review Medicine, General & Internal

Multiple Sclerosis

Daniel S. Reich et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Biochemistry & Molecular Biology

The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis

Philipp Schwenkenbecher et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Add to Collection

Review Clinical Neurology

The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature

S. Jarius et al.

JOURNAL OF NEUROLOGY (2017)

Add to Collection

Article Medicine, General & Internal

Diagnosis of multiple sclerosis: progress and challenges

Wallace J. Brownlee et al.

LANCET (2017)

Add to Collection

Article Multidisciplinary Sciences

CSF profile in primary progressive multiple sclerosis: Re-exploring the basics

Ahmed Abdelhak et al.

PLOS ONE (2017)

Add to Collection

Review Neurosciences

Polyspecific antibodies without persisting antigen in multiple sclerosis, neurolupus and Guillain-Barre syndrome: immune network connectivity in chronic diseases

Hansotto Reiber

ARQUIVOS DE NEURO-PSIQUIATRIA (2017)

Add to Collection

Review Clinical Neurology

Immunosenescence: the Role of Aging in the Predisposition to Neuro-Infectious Complications Arising from the Treatment of Multiple Sclerosis

Elena Grebenciucova et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2017)

Add to Collection

Article Neurosciences

The MRZ reaction in primary progressive multiple sclerosis

Tilman Hottenrott et al.

FLUIDS AND BARRIERS OF THE CNS (2017)

Add to Collection

Review Clinical Neurology

Aging and multiple sclerosis

Shaik Ahmed Sanai et al.

MULTIPLE SCLEROSIS JOURNAL (2016)

Add to Collection

Review Clinical Neurology

Aging and multiple sclerosis

Shaik Ahmed Sanai et al.

MULTIPLE SCLEROSIS JOURNAL (2016)

Add to Collection

Article Immunology

High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis

G. Hassan-Smith et al.

JOURNAL OF NEUROIMMUNOLOGY (2014)

Add to Collection

Review Clinical Neurology

Defining the clinical course of multiple sclerosis The 2013 revisions

Fred D. Lublin et al.

NEUROLOGY (2014)

Add to Collection

Article Multidisciplinary Sciences

Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS

Stefan Presslauer et al.

PLOS ONE (2014)

Add to Collection

Article Geriatrics & Gerontology

B cell immunosenescence: different features of naive and memory B cells in elderly

Silvio Buffa et al.

BIOGERONTOLOGY (2011)

Add to Collection

Review Geriatrics & Gerontology

Multiple Sclerosis in the Elderly Patient

Amer Awad et al.

DRUGS & AGING (2010)

Add to Collection

Article Medicine, General & Internal

A New Equation to Estimate Glomerular Filtration Rate

Andrew S. Levey et al.

ANNALS OF INTERNAL MEDICINE (2009)

Add to Collection

Article Immunology

CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis

Luisa M. Villar et al.

JOURNAL OF NEUROIMMUNOLOGY (2009)

Add to Collection

Article Clinical Neurology

Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid

H. Reiber et al.

MULTIPLE SCLEROSIS JOURNAL (2009)

Add to Collection

Article Clinical Neurology

Clinical characteristics of patients with late-onset multiple sclerosis

Bernhard Kis et al.

JOURNAL OF NEUROLOGY (2008)

Add to Collection

Article Clinical Neurology

Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis

Stefan Presslauer et al.

JOURNAL OF NEUROLOGY (2008)

Add to Collection

Article Immunology

Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry

S Desplat-Jégo et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2005)

Add to Collection

Review Clinical Neurology

Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis -: A consensus statement

MS Freedman et al.

ARCHIVES OF NEUROLOGY (2005)

Add to Collection

Article Clinical Neurology

The diagnosis of primary progressive multiple sclerosis

JS Wolinsky

JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)

Add to Collection

Review Clinical Neurology

Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs

H Reiber et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2001)

Add to Collection

Review Medicine, General & Internal

Medical progress: Multiple sclerosis.

JH Noseworthy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.